Medacta Group (MEDGF) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free MEDGF Stock Alerts $83.91 0.00 (0.00%) (As of 05/13/2024) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | markets.businessinsider.comMedacta announces the results of today's Annual General MeetingApril 30, 2024 | finance.yahoo.comWhat Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?April 16, 2024 | finance.yahoo.comOwning 70% in Medacta Group SA (VTX:MOVE) means that insiders are heavily invested in the company's futureApril 11, 2024 | markets.businessinsider.comMedacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwideApril 9, 2024 | markets.businessinsider.comMedacta publishes 2024 Annual General Meeting invitationApril 2, 2024 | finance.yahoo.comInvesting in Medacta Group (VTX:MOVE) a year ago would have delivered you a 24% gainMarch 19, 2024 | finance.yahoo.comMedacta Group Full Year 2023 Earnings: Misses ExpectationsMarch 16, 2024 | finance.yahoo.comEarnings Miss: Medacta Group SA Missed EPS By 24% And Analysts Are Revising Their ForecastsMarch 13, 2024 | markets.businessinsider.comBuy Rating Affirmed: Medacta Group’s Strong Growth and Market Position Outweigh Temporary Financial SetbacksFebruary 19, 2024 | ca.finance.yahoo.comMedacta Group SA (MOVE.SW)February 2, 2024 | markets.businessinsider.comMedacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023January 30, 2024 | morningstar.comMedacta Group SA Ordinary Shares MOVEJanuary 18, 2024 | finance.yahoo.comA Look At The Intrinsic Value Of Medacta Group SA (VTX:MOVE)November 29, 2023 | markets.businessinsider.comMedacta further expands in Rancate, Switzerland, doubling its production capability to support the future growthNovember 23, 2023 | finance.yahoo.comMedacta Group (VTX:MOVE) Will Want To Turn Around Its Return TrendsOctober 25, 2023 | finance.yahoo.comAfter the recent decline, Medacta Group SA (VTX:MOVE) CEO Francesco Siccardi's holdings have lost 6.0% of their valueOctober 12, 2023 | markets.businessinsider.comA new study confirms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical applicationOctober 11, 2023 | finance.yahoo.comIf EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An OpportunitySeptember 22, 2023 | markets.businessinsider.comMedacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023August 10, 2023 | finance.yahoo.comCalculating The Fair Value Of Medacta Group SA (VTX:MOVE)July 28, 2023 | markets.businessinsider.comMedacta Group SA: 2023 Half-Year Unaudited Top-Line FiguresJune 9, 2023 | finance.yahoo.comMedacta Group's (VTX:MOVE) Returns On Capital Not Reflecting Well On The BusinessMay 26, 2023 | finance.yahoo.comInvestors three-year returns in Medacta Group (VTX:MOVE) have not grown faster than the company's underlying earnings growthMay 5, 2023 | markets.businessinsider.comMedacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgeryApril 27, 2023 | markets.businessinsider.comMedacta Group SA: Medacta announces the results of today's Annual General MeetingApril 11, 2023 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About Medacta Group SA (VTX:MOVE)?March 29, 2023 | markets.businessinsider.comMedacta publishes 2023 Annual General Meeting invitationMarch 19, 2023 | finance.yahoo.comMedacta Group Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsMarch 17, 2023 | marketwatch.comMedacta Reports Lower 2022 Profit, Predicts Higher 2023 RevenueMarch 12, 2023 | finance.yahoo.comGeisinger Health Plan, Medacta announce first spinal fusion lifetime guaranteeMarch 3, 2023 | wsj.comMedacta Group S.A.January 12, 2023 | finance.yahoo.comMedacta Group SA (6MD.F)January 10, 2023 | markets.businessinsider.comMedacta Group SA: First NextAR surgeries in Japan with the award-winning NextAR Augmented Reality Surgical PlatformDecember 30, 2022 | finance.yahoo.comThere Are Reasons To Feel Uneasy About Medacta Group's (VTX:MOVE) Returns On CapitalDecember 16, 2022 | finance.yahoo.comMedacta Group (VTX:MOVE) sheds 4.2% this week, as yearly returns fall more in line with earnings growthDecember 1, 2022 | finance.yahoo.comMedacta Group SA (VTX:MOVE) insiders, who hold 70% of the firm would be disappointed by the recent pullbackNovember 17, 2022 | finance.yahoo.comWhen Should You Buy Medacta Group SA (VTX:MOVE)?November 15, 2022 | markets.businessinsider.comMedacta Group SA announces the final settlement in the Conformis caseNovember 4, 2022 | markets.businessinsider.comMedacta Group SA: Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN Double Mobility ConverterNovember 2, 2022 | finance.yahoo.comWill Weakness in Medacta Group SA's (VTX:MOVE) Stock Prove Temporary Given Strong Fundamentals?October 6, 2022 | investing.comMedacta Group SA (MOVE)September 21, 2022 | finance.yahoo.comMedacta Announces First Revision Surgeries in the US Using the Unique-on-the-Market and Innovative MyKnee R Patient-Specific SolutionSeptember 9, 2022 | markets.businessinsider.comMedacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 27.5% in the first semester 2022July 29, 2022 | markets.businessinsider.comMedacta Group SA reports 19.0% growth of half-year revenue Get Medacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDGF and its competitors with MarketBeat's FREE daily newsletter. Email Address **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25! Click for Zack's full report MEDGF Media Mentions By Week MEDGF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEDGF News Sentiment▼0.000.42▲Average Medical News Sentiment MEDGF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEDGF Articles This Week▼00▲MEDGF Articles Average Week Get Medacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDGF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cell MedX News Today Cochlear News Today Evome Medical Technologies News Today GN Store Nord A/S News Today Hamilton Thorne News Today Heart Test Laboratories News Today Ion Beam Applications News Today Odyssey Health News Today Perimeter Medical Imaging AI News Today PetVivo News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MEDGF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold"The Biggest Drug Ever" Is ComingBehind the MarketsMost important medical advance in 100 yearsThe Oxford ClubDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
